Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Motor Fluctuations in Parkinson's Disease
NCT00359723Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate in Parkinson's disease (PD), sponsored by Oregon Health & Science University. Started Jul 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00359723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359723.